Merck, Pfizer Sue Mylan to Block Proposed Copy of AzaSite (1)Merck & Co. (MRK) M Mylan told Pfizer, Merck and InSite Vision Inc. (INSV) Pfizer, the world's largest drugmaker, has a license with InSite to sell AzaSite, and InSite has a marketing agreement with Inspire Pharmaceuticals Inc., a unit of Merck. BusinessWeek, 1 day ago |
45 images for pfizer drugmaker pfizer | ||||
Teva, Sun to pay $2.15 bn to Pfizer, Takeda to settle patent suitBiospectrum Singapore: Teva Pharmaceuticals Industries, Israel, and Sun Pharmaceutical Industries, India, are going to pay a combined amount of $2.15 billion to US-based Pfizer in order to settle a patent suit related to its ... Bio Spectrum Asia, 6 days ago
Pfizer in $2.15bn settlement with Teva over Protonix patent
Pharmacy Choice, 5 days ago
Pfizer Announces Infringement Settlement
The American Business Journal, 6 days ago
Teva, Sun Pharma to pay $2.15 bln to settle Pfizer patent suit
Sharenet, 6 days ago
|
Pfizer's slams India's patent regime, says Indian standards are vague and malleableAmerican drugmaker Pfizer Inc has slammed the patent regime in India, telling a domestic industry body in a letter that all patents that the company has managed to get in the country do not have any meaning. The company's chief intellectual property ... Times of India, 2 weeks ago
Indian patent standards are vague, says Pfizer
Economic Times, 2 weeks ago
Pfizer's slams patent regime in India
Economic Times, 2 weeks ago
|
Sun Pharma Declines After $550 Million Pfizer SettlementSun Pharmaceutical Industries Ltd. (SUNP), India's biggest drugmaker by market value, fell the most in two weeks in Mumbai after agreeing to pay more than five times what it had provisioned to settle patent litigation with Pfizer Inc. Sun shares ... Bloomberg, 6 days ago
Sun Pharma Slumps in Mumbai After $550 Million Pfizer Settlement
Washington Post, 6 days ago
|
Pfizer Inc. (PFE), Actavis Inc (ACT): Which Generic Drugmaker Is Your Best Buy Today?Generic-drug makers have considerable tailwinds, making their outperformance in the past year unsurprising. However, most companies within this sub-industry are both cheap and relatively unknown — a combination which bodes well for investors. InsiderMonkey.com, 1 week ago
Which Generic Drugmaker Is Your Best Buy Today?
Motley Fool, 1 week ago
Actavis in talks to buy Irelands Warner Chilcott
Domain-B, 1 month ago
|
Pfizer Inc. CEO Targets Joint Ventures if Control Issues Settled: ReportPfizer CEO Ian Read indicated that the company may pursue joint ventures (JVs) with other drugmakers for developing medicines and expanding in certain countries, the Financial Times reported Thursday. Read suggested that such partnerships could be ... BioSpace, 1 week ago
Pfizer Inc. (PFE) CEO Targets Joint Ventures if Control Issues Settled: Report
BioSpace, 1 week ago
Pfizer Inc., University of California, San Francisco (UCSF) Expands Pact to Develop Small Molecule Drugs
BioSpace, 2 weeks ago
Pfizer Inc. (PFE), University of California, San Francisco (UCSF) Expands Pact to Develop Small Molecule Drugs
BioSpace, 2 weeks ago
|
Pfizer plans offering to pare Zoetis stakePfizer, the world's second-largest drugmaker, said Wednesday its shareholders will be able to trade their Pfizer holdings for Zoetis shares at a discount, depending on the number of shares exchanged. The offer would reduce both the number of Pfizer ... Investors Business Daily, 3 weeks ago
Pfizer Plans to Sell Rest of Its Zoetis Animal Health Stock To Investors
Bloomberg, 3 weeks ago
Pfizer plans exchange with shareholders to reduce stake in animal health spinoff Zoetis
Canadian Business Magazine, 3 weeks ago
Wednesday's most followed in U.S. including Pfizer, Saks, Lowe's, Target, Zale, Toll Brothers and NetApp
Proactive Investors USA, 3 weeks ago
|
Drugmaker Pfizer To Spin Off Rest Of Zoetis June 19Posted 11:40 AM ET Drugmaker Pfizer (PFE) announced Tuesday that it's spinning off the rest of its animal-health unit Zoetis (ZTS) on June 19, just shy of five months after it sold off 20% of it in an IPO. Pfizer will accomplish this with an ... Investors Business Daily, 3 weeks ago
Pfizer To Sell Rest of Zoetis Animal Health Stock To Investors
Washington Post, 3 weeks ago
Pfizer to spin off remainder of Zoetis
M&A Portal, 3 weeks ago
Pfizer to Split Off Rest of Zoetis Animal Health Business
Washington Post, 3 weeks ago
|
Pfizer Planning Benchmark Bonds in First U.S. Offering Since 09Pfizer Inc. (PFE) The world's largest drugmaker intends to offer three-, five-, 10- and 30-year securities as soon as today, according to a person with knowledge of the offering who asked not to be identified because terms aren't set. The notes will ... BusinessWeek, 3 weeks ago
|
Pfizers Q1 net income up 53%, but drugmaker cuts outlookAttiyah for pension scheme for expats SATYENDRA PATHAK DOHA WHAT better than a pension plan to make Qatar even more attractive for expatriates? Administrative Control and Transparency Authority Chairman HE Abdullah bin Hamad al Attiyah recently ... Qatar Tribune, 1 month ago
Pfizer Lowers 2013 Forecast After Drug Sales Missed Analysts Estimates
Bloomberg, 1 month ago
Pfizer 1Q profit jumps versus quarter with big charges, but generic competition reduces sales
Yahoo! Canada, 1 month ago
Pfizer 1Q profit up, but drugmaker cuts outlook
Barchart, 1 month ago
|